Teva Pharmaceutical Industries TEVA
NYSE TEVA
$42.60 +0.85 (+2.04%)
At close: Nov 6, 2026 · 4:00 PM EST

Teva Pharmaceutical Industries (TEVA) Other Accumulated Expenses (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Other Accumulated Expenses came in at $1.04 billion for Q3 2026, down 6.1% from $1.1 billion a year earlier but up 5.0% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Other Accumulated Expenses (2009 - 2026) Analysis & Trends

At the end of FY2025, Teva Pharmaceutical Industries' Other Accumulated Expenses was $1.18 billion, up 15.9% from FY2024.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $1.02 billion in FY2024 (-2.3%), $1.04 billion in FY2023 (+3.9%), $1.01 billion in FY2022 (+11.3%) and $903 million in FY2021 (-3.2%).
  • The five-year range for quarterly Other Accumulated Expenses is $900 million (Q1 2022) to $1.24 billion (Q3 2024).
  • Year-over-year, Other Accumulated Expenses increased in three of the last eight quarters, with an average decline of 2.7%.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2024 (growth of 22.7%), and the weakest in Q2 2025 (a decline of 21.1%).
  • Business Quant data shows TEVA's Other Accumulated Expenses at $987 million (Q2 2026), $1.11 billion (Q1 2026) and $1.18 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Teva Pharmaceutical Industries 49.58 Bn 34.55 Bn 2.44 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.04 Bn
Jun 30, 2026 987.00 Mn
Mar 31, 2026 1.11 Bn
Dec 31, 2025 1.18 Bn
Sep 30, 2025 1.10 Bn
Jun 30, 2025 940.00 Mn
Mar 31, 2025 964.00 Mn
Dec 31, 2024 1.02 Bn
Sep 30, 2024 1.24 Bn
Jun 30, 2024 1.19 Bn
Mar 31, 2024 1.16 Bn
Dec 31, 2023 1.04 Bn
Sep 30, 2023 1.01 Bn
Jun 30, 2023 973.00 Mn
Mar 31, 2023 1.00 Bn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 945.00 Mn
Jun 30, 2022 916.00 Mn
Mar 31, 2022 900.00 Mn
Dec 31, 2021 903.00 Mn
API Access

Teva Pharmaceutical Industries Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TEVA&period=max&api_key=YOUR_API_KEY